207 related articles for article (PubMed ID: 37818364)
21. [Clinical significance of clonal hematopoiesis and disease boundaries in bone marrow failure diseases].
Suzuki T
Rinsho Ketsueki; 2023; 64(6):474-481. PubMed ID: 37407470
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.
Bueno C; Roldan M; Anguita E; Romero-Moya D; Martín-Antonio B; Rosu-Myles M; del Cañizo C; Campos F; García R; Gómez-Casares M; Fuster JL; Jurado M; Delgado M; Menendez P
Haematologica; 2014 Jul; 99(7):1168-75. PubMed ID: 24727813
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of immune pathophysiology in patients with bone marrow failure.
Nakao S
Int J Hematol; 2024 Mar; 119(3):231-239. PubMed ID: 36609840
[TBL] [Abstract][Full Text] [Related]
24. Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
Song Y; Zhao HY; Lyu ZS; Cao XN; Shi MM; Wen Q; Tang FF; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1981-1989. PubMed ID: 29933074
[TBL] [Abstract][Full Text] [Related]
25. Irisin protected hemopoietic stem cells and improved outcome of severe bone marrow failure.
Li H; Kong D; Zhao Y; Liu X; Xiao F; Li X; Hu J; Chen Y; Li S; Wang B; Chen Y; Jiang Y; Liu X; Feng X; Guo Y; Feng X; Ren J; Wang F; Han Y; Donelan W; Yang L; Xu D; Tang D; Zheng C
Biomed Pharmacother; 2023 Dec; 169():115863. PubMed ID: 37952356
[TBL] [Abstract][Full Text] [Related]
26. CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia.
Lu S; Ge M; Zheng Y; Li J; Feng X; Feng S; Huang J; Feng Y; Yang D; Shi J; Chen F; Han Z
Stem Cell Res Ther; 2017 Aug; 8(1):178. PubMed ID: 28764810
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment.
Medinger M; Drexler B; Lengerke C; Passweg J
Front Oncol; 2018; 8():587. PubMed ID: 30568919
[TBL] [Abstract][Full Text] [Related]
28. Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.
Karantanos T; DeZern AE
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101280. PubMed ID: 34404534
[TBL] [Abstract][Full Text] [Related]
29. Granulocytic myeloid-derived suppressor cells to prevent and treat murine immune-mediated bone marrow failure.
Feng X; Kim J; Gonzalez-Matias G; Aggarwal N; Manley AL; Wu Z; Solorzano S; Batchu S; Gao S; Chen J; Young NS
Blood Adv; 2023 Jan; 7(1):73-86. PubMed ID: 35895513
[TBL] [Abstract][Full Text] [Related]
30. Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia.
Li J; Yang S; Lu S; Zhao H; Feng J; Li W; Ma F; Ren Q; Liu B; Zhang L; Zheng Y; Han ZC
PLoS One; 2012; 7(11):e47764. PubMed ID: 23144828
[TBL] [Abstract][Full Text] [Related]
31. Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights
Kong Y
Semin Hematol; 2019 Jul; 56(3):215-220. PubMed ID: 31202433
[TBL] [Abstract][Full Text] [Related]
32. Levamisole suppresses adipogenesis of aplastic anaemia-derived bone marrow mesenchymal stem cells through ZFP36L1-PPARGC1B axis.
Liu LL; Liu L; Liu HH; Ren SS; Dou CY; Cheng PP; Wang CL; Wang LN; Chen XL; Zhang H; Chen MT
J Cell Mol Med; 2018 Sep; 22(9):4496-4506. PubMed ID: 29993187
[TBL] [Abstract][Full Text] [Related]
33. Competitive Repopulation and Allo-Immunologic Pressure Determine Chimerism Kinetics after T Cell-Depleted Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion.
Koster EAS; von dem Borne PA; van Balen P; van Egmond EHM; Marijt EWA; Veld SAJ; Jedema I; Snijders TJF; van Lammeren D; Veelken H; Falkenburg JHF; de Wreede LC; Halkes CJM
Transplant Cell Ther; 2023 Apr; 29(4):268.e1-268.e10. PubMed ID: 36587743
[TBL] [Abstract][Full Text] [Related]
34. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.
Wodnar-Filipowicz A; Lyman SD; Gratwohl A; Tichelli A; Speck B; Nissen C
Blood; 1996 Dec; 88(12):4493-9. PubMed ID: 8977241
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of JAK1/2 inhibition in murine immune bone marrow failure.
Groarke EM; Feng X; Aggarwal N; Manley AL; Wu Z; Gao S; Patel BA; Chen J; Young NS
Blood; 2023 Jan; 141(1):72-89. PubMed ID: 36130301
[TBL] [Abstract][Full Text] [Related]
36. Impairment of hematopoietic stem cell niches in patients with aplastic anemia.
Wu L; Mo W; Zhang Y; Deng H; Li Y; Zhou R; Zhang L; Pan S; Wang S
Int J Hematol; 2015 Dec; 102(6):645-53. PubMed ID: 26440975
[TBL] [Abstract][Full Text] [Related]
37. [Defectiveness of bone marrow mesenchymal stem cells in acquired aplastic anemia].
Zhang JL; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):100-6. PubMed ID: 25616306
[TBL] [Abstract][Full Text] [Related]
38. [Establishing aplastic anemia animal model based on different pathogenesis].
Zhang YC; Zhao MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):285-9. PubMed ID: 25687089
[TBL] [Abstract][Full Text] [Related]
39. Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia.
Zeng W; Maciejewski JP; Chen G; Risitano AM; Kirby M; Kajigaya S; Young NS
Br J Haematol; 2002 Dec; 119(3):803-9. PubMed ID: 12437663
[TBL] [Abstract][Full Text] [Related]
40. Analysis of T-cell clonality in bone marrow of patients with acquired aplastic anaemia.
Melenhorst JJ; Fibbe WE; Struyk L; van der Elsen PJ; Willemze R; Landegent JE
Br J Haematol; 1997 Jan; 96(1):85-91. PubMed ID: 9012692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
